Avricore Health Inc.
AVCR.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1,262.10% | 38.21% | 118.67% | 188.28% | 124.29% |
| Total Depreciation and Amortization | -13.94% | -7.80% | 19.94% | 37.13% | 73.52% |
| Total Amortization of Deferred Charges | -59.68% | -- | -- | -- | 24.00% |
| Total Other Non-Cash Items | 545.24% | 9.26% | -99.04% | -80.03% | -41.59% |
| Change in Net Operating Assets | 65.77% | -174.63% | -194.69% | -6.08% | 16.42% |
| Cash from Operations | 35.87% | 28.27% | -91.95% | 339.07% | 1,118.44% |
| Capital Expenditure | 98.49% | 75.20% | 83.38% | 65.62% | 20.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.54% | -600.00% | -190.91% | -64.71% | -75.68% |
| Cash from Investing | 96.68% | 74.87% | 79.13% | 62.99% | 18.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -93.33% | -43.27% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -93.75% | -152.71% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 402.89% | 366.83% | 30.90% | 386.20% | 54.69% |